| 1 |
Gerard Raphael Dawson |
Merck |
3 |
| 1 |
Mark Stuart Chambers |
Merck |
3 |
| 3 |
Christopher Norbert Johnson |
Astex Therapeutics Limited |
2 |
| 3 |
Graham Dolman |
Nortel Networks Limited |
2 |
| 3 |
Reuben Wu |
Johnsondiversey |
2 |
| 3 |
Jochem Sauer |
Vantico |
2 |
| #7 |
Duncan McL A. Grieve |
Eastman Kodak |
1 |
| #7 |
Michael Barnes |
Smithkline Beeacham P.L.C. |
1 |
| #7 |
Alan Findlay Haughan |
Chdi Foundation |
1 |
| #7 |
Peter Gerard Hiscocks |
Fuisz Technologies |
1 |
| #7 |
Hugh Jonathan Herdon |
Smithkline Beeacham P.L.C. |
1 |
| #7 |
Chris Gale |
— |
1 |
| #7 |
Mark Robson Humphries |
Capsugel Belgium Nv |
1 |
| #7 |
Gilles Raphy |
Chdi Foundation |
1 |
| #7 |
Huw Jones |
Atlantic Pharmaceuticals (Holdings) |
1 |
| #7 |
Ruth McKernan |
Merck |
1 |
| #7 |
Elizabeth A. Saville-Stones |
Chdi Foundation |
1 |
| #7 |
Andrew Colin Share |
Novartis International Pharmaceutical |
1 |
| #7 |
John Frederick Atherall |
Xention Limited |
1 |
| #7 |
Hervé Van De Poël |
Chiesi Farmaceutici S.P.A. |
1 |
| #7 |
John H. Parsons |
Schering Agrochemicals Limited |
1 |
| #7 |
Andrew Jeffries |
Nortel Networks Limited |
1 |
| #7 |
Aaron Custance |
Genomic Solutions |
1 |